VETERINARY ONCOLOGY MARKET ANALYSIS (2020-2027)

Veterinary oncology is subspecialty of veterinary medicine that deals with the diagnosis and treatment of cancer in animals. With emerging technologies, the use of biotechnology products in veterinary medicines is increasing. Despite the costs that many times accompany the development of novel biotechnological products, recombinant virus vector vaccines, recombinant proteins such as bioactive cytokines and immunotherapeutic allergens, therapeutic antibodies, and oncolytic viruses are the result of advancements in biotechnology for veterinary medicines. The benefits associated with using biotechnology products are large-scale production, reduced costs, long-term action, and multiple antigen vaccines.

Market Dynamics

Increasing prevalence of veterinary cancer is expected to boost the global veterinary oncology market growth during the forecast period. For instance, according to the Veterinary Cancer Society, in 2016, cancer is the leading cause of death in 47% of dogs diagnosed with cancer over the age of 10 years; and 32% of cats, where Feline Leukaemia Virus (FeLV) is one of the leading cause of lymphoma in cats. Moreover, according to the Animal Cancer Foundation in 2015, around 6 million new cancer cases in dogs and cats are recorded, annually, in the U.S., of which one-third of all tumors in dogs are skin tumors, while around 20% are mast cell tumors.

However, adverse effects associated with chemotherapies, immunotherapies, and targeted therapies such as diarrhoea, anorexia, decreased appetite, lethargy, neutropenia, emesis, lameness, severe weight loss, and musculoskeletal disorder are major factors restraining the veterinary oncology market growth.

Key features of the study:

This report provides in-depth analysis of the global veterinary oncology market, market size (US$ Mn), and compound annual growth rate (CAGR %) during the forecast period: 2019 – 2026, considering 2018 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players operating in this market
It profiles key players in the global veterinary oncology market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global veterinary oncology market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for global veterinary oncology market, research and consulting firms, new entrants, and financial analysts

Request the sample copy of here:

https://www.coherentmarketinsights.com/insight/request-sample/2995

Download the PDF Brochure here:

https://www.coherentmarketinsights.com/insight/request-pdf/2995

Detailed Segmentation:

Global Veterinary Oncology Market, By Animal Type:

Companion Animal

Equine
Canine
Feline

Livestock Animal

Global Veterinary Oncology Market, By Therapy Type:

Chemotherapy
Combination Therapy
Immunotherapy
Targeted Therapy

Global Veterinary Oncology Market, By Mode of Administration:

Oral
Intravenous

Global Veterinary Oncology Market, By Application:

Canine Lymphoma
Osteosarcoma (OSA)
Mast Cell Cancer
Melanoma
Multiple Myeloma

Global Veterinary Oncology Market, By Distribution Channel:

Hospital Pharmacies
Government Agencies
Retail Pharmacies

Global Veterinary Oncology Market, By Region:

North America

By Country:

U.S.
Canada

By Animal Type:

Companion Animal

Equine
Canine
Feline

Livestock Animal

By Therapy Type:

Chemotherapy
Combination Therapy
Immunotherapy
Targeted Therapy

By Mode of Administration:

Oral
Intravenous

By Application:

Canine Lymphoma
Osteosarcoma (OSA)
Mast Cell Cancer
Melanoma
Multiple Myeloma

By Distribution Channel:

Hospital Pharmacies
Government Agencies
Retail Pharmacies

Europe

By Country:

U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe

By Animal Type:

Companion Animal

Equine
Canine
Feline

Livestock Animal

By Therapy Type:

Chemotherapy
Combination Therapy
Immunotherapy
Targeted Therapy

By Mode of Administration:

Oral
Intravenous

By Application:

Canine Lymphoma
Osteosarcoma (OSA)
Mast Cell Cancer
Melanoma
Multiple Myeloma

By Distribution Channel:

Hospital Pharmacies
Government Agencies
Retail Pharmacies

Asia Pacific

By Country:

Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific

By Animal Type:

Companion Animal

Equine
Canine
Feline

Livestock Animal

By Therapy Type:

Chemotherapy
Combination Therapy
Immunotherapy
Targeted Therapy

By Mode of Administration:

Oral
Intravenous

By Application:

Canine Lymphoma
Osteosarcoma (OSA)
Mast Cell Cancer
Melanoma
Multiple Myeloma

By Distribution Channel:

Hospital Pharmacies
Government Agencies
Retail Pharmacies

Latin America

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

By Animal Type:

Companion Animal

Equine
Canine
Feline

Livestock Animal

By Therapy Type:

Chemotherapy
Combination Therapy
Immunotherapy
Targeted Therapy

By Mode of Administration:

Oral
Intravenous

By Application:

Canine Lymphoma
Osteosarcoma (OSA)
Mast Cell Cancer
Melanoma
Multiple Myeloma

By Distribution Channel:

Hospital Pharmacies
Government Agencies
Retail Pharmacies

Middle East

By Country/Region:

GCC
Israel
Rest of Middle East

By Animal Type:

Companion Animal

Equine
Canine
Feline

Livestock Animal

By Therapy Type:

Chemotherapy
Combination Therapy
Immunotherapy
Targeted Therapy

By Mode of Administration:

Oral
Intravenous

By Application:

Canine Lymphoma
Osteosarcoma (OSA)
Mast Cell Cancer
Melanoma
Multiple Myeloma

By Distribution Channel:

Hospital Pharmacies
Government Agencies
Retail Pharmacies

Africa

By Country/Region:

South Africa
Central Africa
North Africa

By Animal Type:

Companion Animal

Equine
Canine
Feline

Livestock Animal

By Therapy Type:

Chemotherapy
Combination Therapy
Immunotherapy
Targeted Therapy

By Mode of Administration:

Oral
Intravenous

By Application:

Canine Lymphoma
Osteosarcoma (OSA)
Mast Cell Cancer
Melanoma
Multiple Myeloma

By Distribution Channel:

Hospital Pharmacies
Government Agencies
Retail Pharmacies

Company Profiles

Zoetis Inc.*

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Elanco
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
VetDC
Morphogenesis, Inc.
Karyopharm Therapeutics, Inc.
Regeneus Ltd.
AdvaVet, Inc.
Rhizen Pharmaceutical SA

Buy now the market research report here:

https://www.coherentmarketinsights.com/insight/buy-now/2995

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

Customized Market Research Services
Industry Analysis Services
Business Consulting Services
Market Intelligence Services
Long term Engagement Model
Country Specific Analysis

Explore CMI Services here

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: [email protected]

Source:

https://www.coherentmarketinsights.com/market-insight/veterinary-oncology-market-2995